DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that ...
Icon has bought health research and commercialization company Mapi for integration into its existing commercialization team, a deal that bumped Icon’s whole-year revenue guidance to $1.77 billion on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback